The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease: A comparison of three different exercise tests

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 6, 2000, Pages 1897-1901

  Oga, Toru ^a   Nishimura, Koichi ^a   Tsukino, Mitsuhiro ^a   Hajiro, Takashi ^a   Ikeda, Akihiko ^a   Izumi, Takateru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

OXITROPIUM BROMIDE; PLACEBO;

ADULT; AGED; ARTICLE; BICYCLE ERGOMETRY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSPNEA; ENDURANCE; EXERCISE; EXERCISE TEST; FORCED EXPIRATORY VOLUME; HUMAN; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; WALKING; WORKLOAD;

EID: 0034126762     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.6.9905045     Document Type: Article

References (24)

1. 1. Celli, B. R., G. L. Snider, J. Heffner, B. Tiep, I. Ziment, B. Make, S. Braman, G. Olsen, and Y. Phillips. 1995. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 152:S77-S120.
2. 2. Siafakas, N. M., P. Vermeire, N. B. Pride, P. Paoletti, J. Gibson, P. Howard, J. C. Yernault, M. Decramer, T. Higenbottam, D. S. Postma, and J. Rees. 1995. Optimal assessment and management of chronic obstructive pulmonary disease. Eur. Respir. J. 8:1398-1420.
3. 3. Braun, S. R., W. N. McKenzie, C. Copeland, L. Knight, and M. Ellersieck. 1989. A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease. Arch. Intern. Med. 149:544-547.
4. 4. Baigelman, W., and S. Chodosh. 1977. Bronchodilator action of the anticholinergic drug, ipratropium bromide (Sch 1000), as an aerosol in chronic bronchitis and asthma. Chest 71:324-328.
5. 5. Leitch, A. G., J. M. Hopkin, D. A. Ellis, S. Merchant, and G. J. R. McHardy. 1978. The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis. Thorax 33:711-713.
6. 6. Tobin, M. J., J. A. Hughes, and D. C. Hutchison. 1984. Effects of ipratropium bromide and fenoterol aerosols on exercise tolerance. Eur. J. Respir. Dis. 65:441-446.
7. 7. Brown, S. E., R. S. Prager, R. A. Shinto, C. E. Fischer, D. W. Stansbury, and R. W. Light. 1986. Cardiopulmonary responses to exercise in chronic airflow obstruction: effects of inhaled atropine sulfate. Chest 89:7-11.
8. 8. Hay, J. G., P. Stone, J. Carter, S. Church, A. Eyre-Brook, M. G. Pearson, A. A. Woodcock, and P. M. A. Calverley. 1992. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur. Respir. J. 5:659-664.
9. 9. Ikeda, A., K. Nishimura, H. Koyama, N. Sugiura, and T. Izumi. 1994. Oxitropium bromide improves exercise performance in patients with COPD. Chest 106:1740-1745.
10. 10. Spence, D. P. S., J. G. Hay, J. Carter, M. G. Pearson, and P. M. A. Calverley. 1993. Oxygen desaturation and breathlessness during corridor walking in chronic obstructive pulmonary disease: effect of oxitropium bromide. Thorax 48:1145-1150.
11. 11. Mahler, D. A. 1998. Pulmonary rehabilitation. Chest 113:263S-268S.
12. 12. O'Donnell, D. E., M. Lam, and K. A. Webb. 1998. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 158:1557-1565.
13. 13. Medical Section of the American Lung Association. 1994. Standardization of spirometry: 1994 update. Am. Rev. Respir. Dis. 152:1107-1136.
14. 14. Japan Society of Chest Diseases. 1993. The predicted values of pulmonary function testing in Japanese [in Japanese]. Jpn. J. Thorac. Dis. 31:Appendix.
15. 15. Borg, G. A. V. 1982. Psychophysical basis of perceived exertion. Med. Sci. Sports Exerc. 14:377-381.
16. 16. Butland, R. J. A., J. Pang, E. R. Gross, A. A. Woodcock, and D. M. Geddes. 1982. Two-, six-, and 12-minute walking tests in respiratory disease. B.M.J. 284:1607-1608.
17. 17. Tobin, M. J., G. Jenouri, I. Danta, C. Kim, H. Watson, and M. A. Sackner. 1982. Response to bronchodilator drug administration by a new reservoir aerosol delivery system and a review of other auxiliary delivery systems. Am. Rev. Respir. Dis. 126:670-675.
18. 18. Tsukino, M., K. Nishimura, A. Ikeda, T. Hajiro, H. Koyama, and T. Izumi. 1998. Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. Thorax 53:269-273.
19. 19. Ikeda, A., K. Nishimura, H. Koyama, M. Tsukino, M. Mishima, and T. Izumi. 1996. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease. Thorax 51:48-53.
20. 20. Swinburn, C. R., J. M. Wakefield, and P. W. Jones. 1985. Performance, ventilation, and oxygen consumption in three different types of exercise test in patients with chronic obstructive lung disease. Thorax 40: 581-586.
21. 21. Killian, K. J., P. Leblanc, D. H. Martin, E. Summers, N. L. Jones, and E. J. M. Campbell. 1992. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am. Rev. Respir. Dis. 146:935-940.
22. 22. Whipp, B. J., J. A. Davis, F. Torres, and K. A. Wasserman. 1981. A test to determine parameters of aerobic function during exercise. J. Appl. Physiol. 47:1131-1135.
23. 23. Bye, P. T. P., S. D. Anderson, A. J. Woolcock, I. H. Young, and J. A. Alison. 1982. Bicycle endurance performance of patients with interstitial lung disease breathing air and oxygen. Am. Rev. Respir. Dis. 126:1005-1012.
24. 24. Simpson, K., K. Killian, N. McCartney, D. G. Stubbing, and N. L. Jones. 1992. Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation. Thorax 47:70-75.